[
  {
    "ts": null,
    "headline": "Gilead Sciences (GILD) Suffers a Larger Drop Than the General Market: Key Insights",
    "summary": "In the closing of the recent trading day, Gilead Sciences (GILD) stood at $105.87, denoting a -1.53% change from the preceding trading day.",
    "url": "https://finnhub.io/api/news?id=367e15ce3fac067b6215bf0bc1af9dff4b91555ac527258de0bb182ab60b34bd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742508018,
      "headline": "Gilead Sciences (GILD) Suffers a Larger Drop Than the General Market: Key Insights",
      "id": 133325384,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "In the closing of the recent trading day, Gilead Sciences (GILD) stood at $105.87, denoting a -1.53% change from the preceding trading day.",
      "url": "https://finnhub.io/api/news?id=367e15ce3fac067b6215bf0bc1af9dff4b91555ac527258de0bb182ab60b34bd"
    }
  },
  {
    "ts": null,
    "headline": "GILD Stock Down on Report of Cut in HIV Prevention Spending",
    "summary": "Gilead Sciences takes a hit after a Wall Street Journal reports state that the Trump administration is looking to slash funding for HIV prevention in the country.",
    "url": "https://finnhub.io/api/news?id=be9bdf9cb05116790be45848c159ff14b1bd6f2a82757ca20ef1ca5eb0a02b5b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742497200,
      "headline": "GILD Stock Down on Report of Cut in HIV Prevention Spending",
      "id": 133325385,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences takes a hit after a Wall Street Journal reports state that the Trump administration is looking to slash funding for HIV prevention in the country.",
      "url": "https://finnhub.io/api/news?id=be9bdf9cb05116790be45848c159ff14b1bd6f2a82757ca20ef1ca5eb0a02b5b"
    }
  },
  {
    "ts": null,
    "headline": "Oppenheimer doesn’t see threat to Gilead estimates after HHS plans for HIV cuts",
    "summary": "Oppenheimer notes that Gilead (GILD) shares are weak today following reports from multiple media outlets that the Health and Human Services department is mulling cuts to federal HIV prevention funding, though “it sounds like” the cuts would only impact funding for statewide prevention initiatives and not reimbursement for preventative treatments like lenacapavir. Given the uncertainties surrounding this administration, he news “begs the question: What if?” Right now, pre-exposure prophylaxis, or",
    "url": "https://finnhub.io/api/news?id=751bf876d7c1f6d7b09b36bd6c4771df3768a661c67098f2ddccdb5aa89fdd79",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742482849,
      "headline": "Oppenheimer doesn’t see threat to Gilead estimates after HHS plans for HIV cuts",
      "id": 133325386,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Oppenheimer notes that Gilead (GILD) shares are weak today following reports from multiple media outlets that the Health and Human Services department is mulling cuts to federal HIV prevention funding, though “it sounds like” the cuts would only impact funding for statewide prevention initiatives and not reimbursement for preventative treatments like lenacapavir. Given the uncertainties surrounding this administration, he news “begs the question: What if?” Right now, pre-exposure prophylaxis, or",
      "url": "https://finnhub.io/api/news?id=751bf876d7c1f6d7b09b36bd6c4771df3768a661c67098f2ddccdb5aa89fdd79"
    }
  },
  {
    "ts": null,
    "headline": "Trump Trade: Reciprocal tariffs still to start on April 2",
    "summary": "Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: RECIPROCAL TARIFFS: President Donald Trump intends for new reciprocal tariff rates to start on April 2, Andrea Shalal and David Lawder of Reuters report. “The intent is to enact tariffs on April 2,” a white house official said, according to the publication. “Unless the tariff and non-tariff barri",
    "url": "https://finnhub.io/api/news?id=1fb98fafa6e26a50cb813074f816f6d46993b58c90b1e0832c973e130c8fda5b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742479258,
      "headline": "Trump Trade: Reciprocal tariffs still to start on April 2",
      "id": 133323810,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: RECIPROCAL TARIFFS: President Donald Trump intends for new reciprocal tariff rates to start on April 2, Andrea Shalal and David Lawder of Reuters report. “The intent is to enact tariffs on April 2,” a white house official said, according to the publication. “Unless the tariff and non-tariff barri",
      "url": "https://finnhub.io/api/news?id=1fb98fafa6e26a50cb813074f816f6d46993b58c90b1e0832c973e130c8fda5b"
    }
  },
  {
    "ts": null,
    "headline": "Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a Bet",
    "summary": "The average brokerage recommendation (ABR) for Gilead (GILD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?",
    "url": "https://finnhub.io/api/news?id=975ee1dfa9a06d6e797dd9e7bba3de74edea53a7dc8638a148cf721d5cc1a743",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742477410,
      "headline": "Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a Bet",
      "id": 133325388,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "The average brokerage recommendation (ABR) for Gilead (GILD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?",
      "url": "https://finnhub.io/api/news?id=975ee1dfa9a06d6e797dd9e7bba3de74edea53a7dc8638a148cf721d5cc1a743"
    }
  },
  {
    "ts": null,
    "headline": "Defensive Stocks For Unpredictable Trump Policy",
    "summary": "Navigate market volatility with defensive stocks, bonds, and gold.",
    "url": "https://finnhub.io/api/news?id=3a7f34c516b912e4da5e6ab19d098a97e373f71f94dfa6f751a599d77a1b754c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742469633,
      "headline": "Defensive Stocks For Unpredictable Trump Policy",
      "id": 133281246,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2185636755/image_2185636755.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Navigate market volatility with defensive stocks, bonds, and gold.",
      "url": "https://finnhub.io/api/news?id=3a7f34c516b912e4da5e6ab19d098a97e373f71f94dfa6f751a599d77a1b754c"
    }
  },
  {
    "ts": null,
    "headline": "My Dividend Stock Portfolio: New February Dividend Record - 100 Holdings With 11 Buys",
    "summary": "February investments fell below $1,000, mainly in BDCs like Owl Rock Capital and Ares Capital, boosting annual dividend income by $77.",
    "url": "https://finnhub.io/api/news?id=468f86fd4b412eee1971a4620667bbda7347c15c7444f076c7a1ef8f0edb1137",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742463648,
      "headline": "My Dividend Stock Portfolio: New February Dividend Record - 100 Holdings With 11 Buys",
      "id": 133276011,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "February investments fell below $1,000, mainly in BDCs like Owl Rock Capital and Ares Capital, boosting annual dividend income by $77.",
      "url": "https://finnhub.io/api/news?id=468f86fd4b412eee1971a4620667bbda7347c15c7444f076c7a1ef8f0edb1137"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Health Care Fund Q4 2024 Commentary",
    "summary": "Stock selection in life science tools & services, pharmaceuticals and distributors detracted from relative performance, as did an overweight in health care facilities.",
    "url": "https://finnhub.io/api/news?id=8f81827abb6ec00be306ef52a83e31acbe2c243bf3d6f7d992305822a81d2a8e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742461500,
      "headline": "Invesco Health Care Fund Q4 2024 Commentary",
      "id": 133273550,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2154850841/image_2154850841.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Stock selection in life science tools & services, pharmaceuticals and distributors detracted from relative performance, as did an overweight in health care facilities.",
      "url": "https://finnhub.io/api/news?id=8f81827abb6ec00be306ef52a83e31acbe2c243bf3d6f7d992305822a81d2a8e"
    }
  },
  {
    "ts": null,
    "headline": "Trump Administration Weighs Deep Cuts To Domestic HIV Prevention Programs, Gilead Stock Slides",
    "summary": "Gilead Sciences Inc (NASDAQ:GILD) stock is trading lower during the premarket trading session on Wednesday. According to a Tuesday report in the Wall Street Journal, the Health and Human Services Department (HHS) is considering substantial reductions ...",
    "url": "https://finnhub.io/api/news?id=ee2c883b66d1868e5eddeb93929f596eabdce758da104964c5a6d71c60cf97dc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742438174,
      "headline": "Trump Administration Weighs Deep Cuts To Domestic HIV Prevention Programs, Gilead Stock Slides",
      "id": 133325389,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences Inc (NASDAQ:GILD) stock is trading lower during the premarket trading session on Wednesday. According to a Tuesday report in the Wall Street Journal, the Health and Human Services Department (HHS) is considering substantial reductions ...",
      "url": "https://finnhub.io/api/news?id=ee2c883b66d1868e5eddeb93929f596eabdce758da104964c5a6d71c60cf97dc"
    }
  }
]